Human Mast Cells Produce and Differentially Express Both Soluble and Membrane‐Bound Stem Cell Factor

Stem cell factor (SCF), characterized as mast cell growth factor, is known to be produced by fibroblasts, keratinocytes and endothelial cells. Two different splice variants encode for either a soluble (SCF‐1) or a membrane‐bound (SCF‐2) form. In order to explore whether mast cells themselves can produce SCF, we examined cultured cord blood (CBMC) and peripheral‐blood‐derived mast cells (PBMC), mast/basophil cell lines (HMC‐1 and KU‐812), and skin mast cells for SCF expression. On immunocytochemistry, cytoplasmatic SCF‐reactivity was observed in HMC‐1 cells, with additional cell membrane staining in KU‐812, skin and cultured mast cells. Low amounts of SCF could be detected by ELISA in lysates of isolated and unstimulated mast cells and in supernatants of skin cells stimulated with anti‐IgE or Ca‐ionophore A23187. SCF mRNA was detected in all cells, although marked quantitative differences were observed among the various cell types. SCF‐2 mRNA expression was low in HMC‐1 cells while it was marked in skin mast cells, KU‐812 cells, CBMC and PBMC. A time‐dependent, increasing induction of both SCF forms was seen in CBMC and PBMC during culture. After stimulation with A23187 and phorbol myristate acetate, an up‐regulation of SCF mRNA was noted in HMC‐1 and KU‐812 cells, without changes in the relationship of the two splice variants. The differential expression of SCF‐specific mRNA splice variants in immature and mature human mast cells and the secretion of this molecule by these cells may play a role in autocrine stimulation, maintenance of survival and the differentiation of tissue mast cells.

[1]  W. Danho,et al.  High Affinity Human IgE Receptor (FcrRI) ANALYSIS OF FUNCTIONAL DOMAINS OF THE a-SUBUNIT WITH MONOCLONAL ANTIBODIES , 2001 .

[2]  E. Arbustini,et al.  Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. , 1998, Circulation.

[3]  Henz Bm SCF and c-kit in mastocytosis--a Pandora's box holding more theories than proven facts. , 1998 .

[4]  Möller,et al.  Comparative cytokine gene expression: regulation and release by human mast cells , 1998, Immunology.

[5]  B. Henz SCF and c-kit in mastocytosis--a Pandora's box holding more theories than proven facts. , 1998, The Journal of investigative dermatology.

[6]  R. Halaban,et al.  Chymase cleavage of stem cell factor yields a bioactive, soluble product. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Longley,et al.  Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. , 1997, The Journal of investigative dermatology.

[8]  G. Marone,et al.  Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy , 1997, Inflammation Research.

[9]  E. Fiebiger,et al.  Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. , 1996, The Journal of investigative dermatology.

[10]  U. Lippert,et al.  Production of interleukin-6 by human mast cells and basophilic cells. , 1996, The Journal of investigative dermatology.

[11]  B. Czarnetzki,et al.  Expression of stem cell factor in cutaneous mastocytosis , 1995, The British journal of dermatology.

[12]  D. Metcalfe,et al.  Mast cell ontogeny and apoptosis , 1995, Experimental dermatology.

[13]  G. Nilsson,et al.  Stem cell factor is a chemotactic factor for human mast cells. , 1994, Journal of immunology.

[14]  L. Ashman,et al.  Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). , 1994, The Journal of investigative dermatology.

[15]  L. Ashman,et al.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. , 1993, The Journal of clinical investigation.

[16]  D. Schadendorf,et al.  Human mast cells produce IL-8. , 1993, Journal of immunology.

[17]  D. Williams,et al.  Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. , 1993, The New England journal of medicine.

[18]  B. Calabretta,et al.  Role of the KIT protooncogene in normal and malignant human hematopoiesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Kochan,et al.  High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. , 1991, The Journal of biological chemistry.

[20]  P. Leder,et al.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.

[21]  G. Dewald,et al.  Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.

[22]  K. Kishi,et al.  A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. , 1985, Leukemia research.

[23]  R. G. Ham,et al.  Clonal growth of normal human epidermal keratinocytes in a defined medium , 1982, Journal of cellular physiology.